UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 622

Sortiert nach

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

Cancers, 2020-09, Vol.12 (9), p.2645

2020

Link zum Volltext

Verfügbarkeit prüfen

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

Scientific reports, 2018-09, Vol.8 (1), p.13379-10, Article 13379

2018

Link zum Volltext

Verfügbarkeit prüfen

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective

ESMO open, 2020-03, Vol.5 (2), p.e000759, Article e000759

2020

Link zum Volltext

Verfügbarkeit prüfen

Which patients should receive electronic patient-reported outcome measures in clinical practice?

Cancer, 2023-09, Vol.129 (18), p.2915-2916

Di Maio, Massimo

2023

Link zum Volltext

Verfügbarkeit prüfen

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-04, Vol.27 (11), p.1836-1843

2009

Link zum Volltext

Verfügbarkeit prüfen

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

The lancet oncology, 2014-10, Vol.15 (11), p.1254-1262

2014

Link zum Volltext

Verfügbarkeit prüfen

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

Cancer Immunology, Immunotherapy, 2022-04, Vol.71 (4), p.865-874

2022

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review

Cancers, 2020-09, Vol.12 (9), p.2568

2020

Link zum Volltext

Verfügbarkeit prüfen

Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms

Pharmaceutics, 2021-07, Vol.13 (7), p.1014

2021

Link zum Volltext

Verfügbarkeit prüfen

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives

BioMed research international, 2017-01, Vol.2017, p.5618174-13

2017

Link zum Volltext

Verfügbarkeit prüfen

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Nature reviews. Clinical oncology, 2016-05, Vol.13 (5), p.319-325

2016

Link zum Volltext

Verfügbarkeit prüfen

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Therapeutic advances in medical oncology, 2021, Vol.13, p.17588359211019675-17588359211019675

2021

Link zum Volltext

Verfügbarkeit prüfen

Heterogeneity of treatment effects in malignant pleural mesothelioma

The Lancet (British edition), 2021-07, Vol.398 (10297), p.301-302

2021

Link zum Volltext

Verfügbarkeit prüfen

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Immunotherapy, 2018-10, Vol.10 (14), p.1229-1239

2018

Link zum Volltext

Verfügbarkeit prüfen

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities

PloS one, 2016-07, Vol.11 (7), p.e0159146-e0159146

2016

Link zum Volltext

Verfügbarkeit prüfen

Quality of life: an important element of treatment value

The lancet oncology, 2017-12, Vol.18 (12), p.1557-1558

Di Maio, Massimo

2017

Link zum Volltext

Verfügbarkeit prüfen

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study

Immunotherapy, 2020-02, Vol.12 (2), p.151-159

2020

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in patients with lung cancer: the way forward

The lancet oncology, 2020-05, Vol.21 (5), p.617-619

2020

Link zum Volltext

Verfügbarkeit prüfen

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression

International journal of clinical oncology, 2018-04, Vol.23 (2), p.281-286

2018

Link zum Volltext

Verfügbarkeit prüfen

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

Journal of clinical oncology, 2020-10, Vol.38 (28), p.JCO2001225-3324

2020

Link zum Volltext

Verfügbarkeit prüfen

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

Frontiers in oncology, 2019-04, Vol.9, p.264-264

2019

Link zum Volltext

Verfügbarkeit prüfen

Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)”

International journal of cancer, 2022-12, Vol.151 (12), p.2291-2292

2022

Link zum Volltext

Verfügbarkeit prüfen

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications

Critical reviews in oncology/hematology, 2021-01, Vol.157, p.103185, Article 103185

2021

Link zum Volltext

Verfügbarkeit prüfen

Is human hepatocellular carcinoma a hormone-responsive tumor

World journal of gastroenterology : WJG, 2008-03, Vol.14 (11), p.1682-1689

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 622

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(570)
Mit Volltextzugriff
(557)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(438)
Life Sciences & Biomedicine
(409)
Humans
(323)
Oncology
(310)
Female
(147)
Male
(134)
Aged
(120)
Middle Aged
(114)
Chemotherapy
(82)
Adult
(81)
Lung Neoplasms - Drug Therapy
(69)
Treatment Outcome
(69)
Tumors
(67)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(64)
Prognosis
(60)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(58)
Aged, 80 And Over
(57)
Cancer
(55)
Antineoplastic Agents - Therapeutic Use
(50)
Clinical Trials
(50)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(69)
Lung Cancer
(30)
Critical Reviews In Oncology/hematology
(23)
European Journal Of Cancer
(16)
Cancers
(15)
The Lancet Oncology
(14)
Tumori
(14)
Clinical Lung Cancer
(12)
Bmc Cancer
(10)
Cancer Treatment Reviews
(10)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(18)
... seit 30 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Adding PD-1/PD-L1 Inhibitors to Chemotherapy for the First-Line Treatment of Extensive Stage Small Cell Lung Cancer (SCLC): A Meta-Analysis of Randomized Trials

The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis

Cancer care during the spread of coronavirus disease 2019 (COVID-19) in Italy: young oncologists’ perspective

Which patients should receive electronic patient-reported outcome measures in clinical practice?

Meta-Analysis of Single-Agent Chemotherapy Compared With Combination Chemotherapy As Second-Line Treatment of Advanced Non–Small-Cell Lung Cancer

Six versus fewer planned cycles of first-line platinum-based chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data

Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation

Evaluation of Cognitive Function in Trials Testing New-Generation Hormonal Therapy in Patients with Prostate Cancer: A Systematic Review

Accuracy of Dose Administered to Children Using Off-Labelled or Unlicensed Oral Dosage Forms

Immunotherapy for Patients with Advanced Urothelial Cancer: Current Evidence and Future Perspectives

Patient-reported outcomes in the evaluation of toxicity of anticancer treatments

Selpercatinib in RET fusion-positive non-small-cell lung cancer (SIREN): a retrospective analysis of patients treated through an access program

Heterogeneity of treatment effects in malignant pleural mesothelioma

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

What Medical Oncologist Residents Think about the Italian Speciality Schools: A Survey of the Italian Association of Medical Oncology (AIOM) on Educational, Clinical and Research Activities

Quality of life: an important element of treatment value

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study

Quality of life in patients with lung cancer: the way forward

MMC/UFT/LV in refractory colorectal cancer: phase II study and analysis of predictive variables of progression

Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience

Individual Patient Data Meta-Analysis of FOLFOXIRI Plus Bevacizumab Versus Doublets Plus Bevacizumab as Initial Therapy of Unresectable Metastatic Colorectal Cancer

Chemotherapy in Combination With Immune Checkpoint Inhibitors for the First-Line Treatment of Patients With Advanced Non-small Cell Lung Cancer: A Systematic Review and Literature-Based Meta-Analysis

Comments on “Abiraterone acetate plus prednisolone for metastatic patients starting hormone therapy: 5‐year follow‐up results from the STAMPEDE randomised trial (NCT00268476)”

Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications

Is human hepatocellular carcinoma a hormone-responsive tumor

Suchergebnisse filtern